Increased CDA expression/activity in males contributes to decreased cytidine analogue half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy

PURPOSE: The cytidine analogues 5-azacytidine and decitabine, used to treat myelodysplastic syndromes (MDS), produce a molecular epigenetic effect, depletion of DNA-methyltransferase (DNMT1). This action is S-phase dependent. Hence, genetic factors that decrease the half-lives of these drugs could i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mahfouz, Reda Z, Jankowska, Ania, Ebrahem, Quteba, Gu, Xiaorong, Visconte, Valeria, Tabarroki, Ali, Terse, Pramod, Covey, Joseph, Chan, Kenneth, Ling, Yonghua, Engelke, Kory J., Sekeres, Mikkael A., Tiu, Ramon, Maciejewski, Jaroslaw, Radivoyevitch, Tomas, Saunthararajah, Yogen
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3577958/
https://ncbi.nlm.nih.gov/pubmed/23287564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1722
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados